Cargando…

The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders

The interleukin-1 receptor type 1 (IL-1R1) holds pivotal roles in the immune system, as it is positioned at the “epicenter” of the inflammatory signaling networks. Increased levels of the cytokine IL-1 are a recognized feature of the immune response in the central nervous system (CNS) during injury...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luís, João P., Simões, Carlos J. V., Brito, Rui M. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915186/ https://www.ncbi.nlm.nih.gov/pubmed/35163653 http://dx.doi.org/10.3390/ijms23031731

Ejemplares similares

Editorial: Novel therapeutic approaches to treat neuroinflammation in the central nervous system
por: German, Nadezhda A.
Publicado: (2023)

Central Nervous System Parasitosis and Neuroinflammation Ameliorated by Systemic IL-10 Administration in Trypanosoma brucei-Infected Mice
por: Rodgers, Jean, et al.
Publicado: (2015)

Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System
por: Rathod, Sumit S., et al.
Publicado: (2023)

Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands
por: Bogár, Ferenc, et al.
Publicado: (2022)

Under the influence: environmental factors as modulators of neuroinflammation through the IL-10/IL-10R axis
por: Bugbee, Eryn, et al.
Publicado: (2023)

Nutritional Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of Neuroinflammation and Neurological Disease
por: Estrada, José Antonio, et al.
Publicado: (2019)

When friend turns foe: central and peripheral neuroinflammation in central nervous system injury
por: Marcet, Paul, et al.
Publicado: (2017)

CSF-1 maintains pathogenic but not homeostatic myeloid cells in the central nervous system during autoimmune neuroinflammation
por: Hwang, Daniel, et al.
Publicado: (2022)

Neuroinflammation as Fuel for Axonal Regeneration in the Injured Vertebrate Central Nervous System
por: Bollaerts, Ilse, et al.
Publicado: (2017)

Neuroinflammation and glial activation in the central nervous system: a metabolic perspective
por: Virtuoso, Assunta, et al.
Publicado: (2022)

Increased Levels of IL-16 in the Central Nervous System during Neuroinflammation Are Associated with Infiltrating Immune Cells and Resident Glial Cells
por: Hridi, Shehla U, et al.
Publicado: (2021)

Recent Advances in Progresses and Prospects of IL-37 in Central Nervous System Diseases
por: Li, Xinrui, et al.
Publicado: (2022)

Developmental endothelial locus-1 (Del-1) is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination
por: Choi, Eun Young, et al.
Publicado: (2014)

Opposing Roles of Interferon-Gamma on Cells of the Central Nervous System in Autoimmune Neuroinflammation
por: Ottum, Payton A., et al.
Publicado: (2015)

Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease
por: Yan, Jingya, et al.
Publicado: (2021)

Galectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases
por: Ge, Meng-Meng, et al.
Publicado: (2022)

Carnosine quenches the reactive carbonyl acrolein in the central nervous system and attenuates autoimmune neuroinflammation
por: Spaas, Jan, et al.
Publicado: (2021)

Editorial: Noncoding RNA-based spatiotemporal modulation and therapeutics in neuroinflammation
por: Cai, Zhongdi, et al.
Publicado: (2023)

Central Nervous System Barriers Impact Distribution and Expression of iNOS and Arginase-1 in Infiltrating Macrophages During Neuroinflammation
por: Ivan, Daniela C., et al.
Publicado: (2021)

Integrating Lipidomics and Transcriptomics Reveals the Crosstalk Between Oxidative Stress and Neuroinflammation in Central Nervous System Demyelination
por: Zhao, Zhi-jie, et al.
Publicado: (2022)

TPL2 mediates IL-17R signaling in neuroinflammation
por: Xiao, Yichuan, et al.
Publicado: (2015)

Conformational Dynamics of the Soluble and Membrane-Bound Forms of Interleukin-1 Receptor Type-1: Insights into Linker Flexibility and Domain Orientation
por: Luís, João P., et al.
Publicado: (2022)

Neuroinflammation and Neurodegeneration of the Central Nervous System from Air Pollutants: A Scoping Review
por: Armas, Frances Vivienne, et al.
Publicado: (2022)

Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation
por: García-Rodríguez, Claudia, et al.
Publicado: (2023)

IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression
por: Casella, Giacomo, et al.
Publicado: (2017)

The Case for TAAR1 as a Modulator of Central Nervous System Function
por: Rutigliano, Grazia, et al.
Publicado: (2018)

Peripherally Induced Regulatory T Cells: Recruited Protectors of the Central Nervous System against Autoimmune Neuroinflammation
por: Jones, Andrew, et al.
Publicado: (2017)

Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration
por: Ayub, Maria, et al.
Publicado: (2021)

Down-regulation of interleukin 7 receptor (IL-7R) contributes to central nervous system demyelination
por: Lei, Xudan, et al.
Publicado: (2017)

Insights Into the Role of CSF1R in the Central Nervous System and Neurological Disorders
por: Hu, Banglian, et al.
Publicado: (2021)

Mechanotransduction: Exploring New Therapeutic Avenues in Central Nervous System Pathology
por: Rocha, Daniela Nogueira, et al.
Publicado: (2022)

Editorial: Targeting Neuroinflammation in Central Nervous System Disorders: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
por: Pérez, Mariela Fernanda, et al.
Publicado: (2021)

Editorial: A Microbial View of Central Nervous System Disorders: Interplay Between Microorganisms, Neuroinflammation and Behaviour
por: Cossu, Davide, et al.
Publicado: (2021)

PKC modulator bryostatin-1 therapeutically targets CNS innate immunity to attenuate neuroinflammation and promote remyelination
por: Gharibani, Payam, et al.
Publicado: (2023)

Clinical outcomes of a cohort of patients with central nervous system metastases from thyroid cancer
por: Simões-Pereira, Joana, et al.
Publicado: (2016)

The Role of IRE1 Signaling in the Central Nervous System Diseases
por: Ni, Haibo, et al.
Publicado: (2018)

Modulation of lymphatic transport in the central nervous system
por: Li, Wenzhong, et al.
Publicado: (2022)

IL-37 exerts therapeutic effects in experimental autoimmune encephalomyelitis through the receptor complex IL-1R5/IL-1R8
por: Sánchez-Fernández, Alba, et al.
Publicado: (2021)

Editorial: Mechanisms of Neuronal Recovery in the Central Nervous System
por: Tovar-y-Romo, Luis B., et al.
Publicado: (2021)

The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases
por: Tan, Rui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bbibbnm42smigk7p8rs51k8m3f